Past beta-lactam reaction | Initial regimen | Comments |
Mild cutaneous reactions to a penicillin (eg, mild drug eruptions, with or without pruritus, immediate or delayed), including isolated mild hives to a penicillin without other signs of anaphylaxis, especially if the reaction occurred in childhood and/or >10 years ago. |
| If Listeria coverage is required (eg, patients >50 years of age and/or immunocompromised hosts), trimethoprim-sulfamethoxazole should be initiated. Immunocompromised patients generally require expanded gram-negative coverage (eg, cefepime or meropenem instead of ceftriaxone or cefotaxime).* If meropenem is used, it provides sufficient coverage for Listeria when used as part of an initial empiric regimen. |
Isolated mild hives to a cephalosporin without other signs of anaphylaxis (especially if the reaction occurred in childhood and/or >10 years ago) Or Mild delayed type reactions to cephalosporins. |
| Meropenem provides sufficient coverage for Listeria and Pseudomonas aeruginosa when used as part of an initial empiric regimen.* |
Severe immediate allergy (eg, anaphylaxis) to a penicillin and/or cephalosporin Or SJS/TEN, DRESS, or AGEP with any beta-lactam other than aztreonam. |
| If Listeria coverage is required (eg, patients >50 years of age and/or immunocompromised hosts), trimethoprim-sulfamethoxazole should be initiated. Immunocompromised patients generally require expanded gram-negative coverage.* If expanded gram-negative coverage is required, aztreonam should be added as long as there is no history of serious allergy (eg, anaphylaxis, SJS/TEN, DRESS, AGEP) to aztreonam itself or an immediate or IgE-mediated allergy to ceftazidime. |
Other uncommon forms of hypersensitivity | Initial regimen | Comments |
Interstitial nephritisΔ, or drug-induced liver diseaseΔ◊, or drug-induced cytopeniaΔ, or serum sicknessΔ
|
| If Listeria coverage is required (eg, patients >50 years of age and/or immunocompromised hosts), trimethoprim-sulfamethoxazole should be initiated. Immunocompromised patients generally require expanded gram-negative coverage (eg, cefepime or meropenem instead of ceftriaxone or cefotaxime).* If meropenem is used, it provides sufficient coverage for Listeria when used as part of an initial empiric regimen. |
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟